Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Allo Transplantation With Mylotarg, Fludarabine and Melphalan for AML, CML and MDS

This study has been completed.
Information provided by (Responsible Party):
M.D. Anderson Cancer Center Identifier:
First received: June 5, 2002
Last updated: July 31, 2012
Last verified: July 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2006
  Primary Completion Date: March 2005 (Final data collection date for primary outcome measure)